Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Avai Bio (AVAI) Return on Sales (2019 - 2022)

Avai Bio's Return on Sales history spans 3 years, with the latest figure at 4.14% for Q4 2022.

  • For Q4 2022, Return on Sales changed N/A year-over-year to 4.14%; the TTM value through Dec 2022 reached 4.14%, changed N/A, while the annual FY2025 figure was 2.92%, 26648.0% down from the prior year.
  • Return on Sales for Q4 2022 was 4.14% at Avai Bio, up from 1.18% in the prior quarter.
  • Across five years, Return on Sales topped out at 4.14% in Q4 2022 and bottomed at 19.76% in Q3 2019.
  • The 3-year median for Return on Sales is 0.18% (2020), against an average of 3.14%.
  • The largest YoY upside for Return on Sales was 2099bps in 2020 against a maximum downside of 261bps in 2020.
  • A 3-year view of Return on Sales shows it stood at 18.29% in 2019, then soared by 115bps to 2.7% in 2020, then surged by 54bps to 4.14% in 2022.
  • Per Business Quant, the three most recent readings for AVAI's Return on Sales are 4.14% (Q4 2022), 1.18% (Q3 2022), and 0.7% (Q2 2022).